Phase 0 3 trials
Phase 0
NCT05664880 Jun 2023 → Jun 2026 overdue chronic pancreatitis Cedars-Sinai Medical Center
Recruiting
No outcome recorded
Phase 0
NCT05365893 Oct 2021 → Dec 2025 overdue pancreatic ductal adenocarcinoma Fox Chase Cancer Center
Active not recruiting
No outcome recorded
Phase 0
NCT03519308 Jul 2020 → Apr 2022 malignant pancreatic neoplasm Abramson Cancer Center at Penn Medicine
Terminated
No outcome recorded
Stop: Enrollment
Phase 1 9 trials
Phase 1
NCT03883919 Jul 2019 → Mar 2021 malignant pancreatic neoplasm Washington University School of Medicine
Completed
No outcome recorded
Phase 1
NCT03520790 Dec 2018 → Jul 2024 malignant pancreatic neoplasm Dana-Farber Cancer Institute
Terminated
No outcome recorded
Phase 1
NCT03300921 Sep 2017 → Aug 2020 malignant pancreatic neoplasm Abramson Cancer Center at Penn Medicine
Terminated
No outcome recorded
Phase 1
NCT02930902 Feb 2017 → Jan 2023 digestive system carcinoma , malignant exocrine pancreas neoplasm M.D. Anderson Cancer Center
Completed
No outcome recorded
Phase 1
NCT02030860 Jan 2014 → Dec 2015 pancreatic adenocarcinoma Abramson Cancer Center at Penn Medicine
Completed
No outcome recorded
Phase 1
NCT01197664 Aug 2010 → Jul 2012 rectum mucinous adenocarcinoma Wake Forest University Health Sciences
Terminated
No outcome recorded
Stop: Business
Phase 1
NCT00637897 Mar 2008 → Nov 2011 breast cancer Wake Forest University Health Sciences
Completed
No outcome recorded
Phase 1
NCT00258258 Aug 2005 → Mar 2009 plasma cell myeloma Roswell Park Cancer Institute
Terminated
No outcome recorded
Stop: Enrollment
Phase 1
NCT00217477 Aug 2004 → May 2013 cancer of unknown primary site Roswell Park Cancer Institute
Completed
No outcome recorded
Phase 2 18 trials · 1 met primary · 2 missed
Phase 2
NCT07856914 Sep 2026 → Sep 2030 expected peritoneal carcinoma , peritoneal carcinomatosis Patrick Wagner, MD, FACS
Not yet recruiting
No outcome recorded
Phase 2
NCT04617067 Oct 2020 → Sep 2022 malignant pancreatic neoplasm Cancer Trials Ireland
Completed
Missed primary
Phase 2
NCT04524702 Sep 2020 → Jun 2023 pancreatic adenocarcinoma Emory University
Completed
No outcome recorded
Phase 2
NCT04054362 Nov 2018 → Feb 2021 malignant pancreatic neoplasm Barts & The London NHS Trust
Completed
No outcome recorded
Phase 2
NCT03415854 Jan 2018 → Dec 2023 pancreatic ductal adenocarcinoma HonorHealth Research Institute
Completed
No outcome recorded
Phase 2
NCT03138720 May 2017 → Jul 2023 pancreatic adenocarcinoma HonorHealth Research Institute
Completed
No outcome recorded
Phase 2
NCT02754726 Apr 2016 → Apr 2023 pancreatic ductal adenocarcinoma HonorHealth Research Institute
Completed
No outcome recorded
Phase 2
NCT02686827 Oct 2015 → Apr 2016 hypersensitivity reaction disease Laurian Jongejan
Completed
No outcome recorded
Phase 2
NCT01393808 Sep 2011 → Jul 2015 type 2 diabetes mellitus Mario Negri Institute for Pharmacological Research
Completed
Met primary
Phase 2
NCT00990704 Oct 2009 → May 2010 secondary hyperparathyroidism of renal origin Abbott
Completed
Missed primary
Phase 2
NCT01220050 Sep 2009 → Jul 2012 secondary hyperparathyroidism of renal origin Mario Negri Institute for Pharmacological Research
Completed
No outcome recorded
Phase 2
NCT00634582 Jan 2009 → Jan 2013 metastatic malignant neoplasm , prostate cancer Wake Forest University Health Sciences
Terminated
No outcome recorded
Stop: Enrollment
Phase 2
NCT00701805 Jul 2008 → Dec 2009 secondary hyperparathyroidism Abbott
Completed
No outcome recorded
Phase 2
NCT00667576 Apr 2008 → Mar 2009 chronic kidney disease , secondary hyperparathyroidism of renal origin Abbott
Completed
No outcome recorded
Phase 2
NCT00646932 Nov 2005 → Feb 2007 chronic kidney disease Abbott
Completed
No outcome recorded
Phase 2
NCT00686751 Dec 2004 → Sep 2007 cardiovascular disorder , end stage renal failure , inflammatory disease Renal Research Institute
Completed
No outcome recorded
Phase 2
NCT00064376 May 2003 → Nov 2005 leukemia , myelodysplastic syndrome Cedars-Sinai Medical Center
Completed
No outcome recorded
Phase 2
NCT00053378 Jan 2002 → ? —
Abbott
Completed
No outcome recorded
Show 8 more trials Phase 3 17 trials · 3 met primary · 1 missed
Phase 3
NCT04994080 Feb 2022 → Mar 2023 secondary hyperparathyroidism of renal origin Chengdu Suncadia Medicine Co., Ltd.
Unknown
No outcome recorded
Phase 3
NCT04064827 Sep 2020 → Jun 2025 chronic kidney disease , secondary hyperparathyroidism of renal origin AbbVie
Terminated
No outcome recorded
Phase 3
NCT02282813 Apr 2013 → May 2015 chronic kidney disease , secondary hyperparathyroidism of renal origin , vitamin D deficiency OPKO Health, Inc.
Completed
No outcome recorded
Phase 3
NCT01694160 Jan 2013 → Jan 2015 proteinuria Oslo University Hospital
Completed
No outcome recorded
Phase 3
NCT01820767 Aug 2012 → Oct 2013 chronic kidney disease Ricardo Mouzo Mirco
Completed
No outcome recorded
Phase 3
NCT01382212 Oct 2011 → Apr 2015 end stage renal failure , secondary hyperparathyroidism of renal origin AbbVie
Completed
No outcome recorded
Phase 3
NCT01680198 Jun 2011 → Aug 2012 chronic kidney disease Fondazione C.N.R./Regione Toscana "G. Monasterio", Pisa, Italy
Completed
Met primary
Phase 3
NCT01341782 May 2011 → Apr 2012 secondary hyperparathyroidism AbbVie
Completed
No outcome recorded
Phase 3
NCT01020487 Feb 2010 → May 2014 chronic kidney disease AbbVie
Completed
Met primary
Phase 3
NCT01012414 Jan 2010 → May 2011 chronic kidney disease , coronary artery disorder , secondary hyperparathyroidism , vitamin D deficiency Thomas Jefferson University
Terminated
No outcome recorded
Stop: Enrollment
Phase 3
NCT00497146 Feb 2008 → Sep 2010 chronic kidney disease AbbVie
Completed
Missed primary
Phase 3
NCT00599963 Jan 2008 → Oct 2009 IgA glomerulonephritis Chinese University of Hong Kong
Withdrawn
No outcome recorded
Stop: Business
Phase 3
NCT00417612 Jan 2007 → Aug 2012 X-linked hypophosphatemic rickets , hyperparathyroidism Yale University
Completed
Met primary
Phase 3
NCT00091975 Aug 2004 → ? kidney disorder Abbott
Completed
No outcome recorded
Phase 3
NCT00048438 Feb 2002 → ? chronic kidney disease Abbott
Completed
No outcome recorded
Phase 3
NCT00048516 Feb 2002 → ? chronic kidney disease Abbott
Completed
No outcome recorded
Phase 3
NCT00048451 Feb 2002 → ? chronic kidney disease Abbott
Completed
No outcome recorded
Show 7 more trials Phase 4 20 trials · 2 met primary
Phase 4
NCT02876211 Dec 2014 → Aug 2022 anemia Hospital Son Espases
Terminated
No outcome recorded
Phase 4
NCT01939977 Jan 2014 → Sep 2015 secondary hyperparathyroidism of renal origin Fundación Senefro
Completed
Met primary
Phase 4
NCT01725113 Nov 2012 → Dec 2013 hypercalcemia disease , hyperphosphatemia , kidney failure , secondary hyperparathyroidism Winthrop University Hospital
Terminated
No outcome recorded
Stop: Business
Phase 4
NCT02372695 Jul 2012 → May 2013 —
Effice Servicios Para la Investigacion S.L.
Terminated
No outcome recorded
Phase 4
NCT01506947 May 2012 → Apr 2016 end stage renal failure , secondary hyperparathyroidism AbbVie
Completed
No outcome recorded
Phase 4
NCT01820078 May 2012 → Sep 2013 chronic kidney disease Fundación Renal Iñigo Alvarez De Toledo
Terminated
No outcome recorded
Stop: Enrollment
Phase 4
NCT03023748 Sep 2011 → Dec 2017 end stage renal failure , secondary hyperparathyroidism of renal origin The University of Hong Kong
Unknown
No outcome recorded
Phase 4
NCT01768351 Oct 2010 → Mar 2011 anemia , chronic kidney disease Federico II University
Completed
Met primary
Phase 4
NCT01163162 Aug 2010 → Mar 2011 chronic kidney disease Indiana University
Completed
No outcome recorded
Phase 4
NCT01331317 Apr 2010 → Apr 2012 cardiovascular disorder , diabetic kidney disease Peter Rossing
Completed
No outcome recorded
Phase 4
NCT00891813 May 2009 → Sep 2010 chronic kidney disease , hypercalcemia disease , secondary hyperparathyroidism Abbott
Completed
No outcome recorded
Phase 4
NCT00823303 Feb 2009 → May 2013 chronic kidney disease , secondary hyperparathyroidism Washington University School of Medicine
Completed
No outcome recorded
Phase 4
NCT00664430 Jan → Jun 2009 secondary hyperparathyroidism Abbott
Terminated
No outcome recorded
Stop: Enrollment
Phase 4
NCT00454350 Feb → Jul 2007 secondary hyperparathyroidism of renal origin Genzyme, a Sanofi Company
Completed
No outcome recorded
Phase 4
NCT00135304 Aug 2005 → Oct 2006 secondary hyperparathyroidism of renal origin Amgen
Completed
No outcome recorded
Phase 4
NCT00307840 Feb → Jul 2005 secondary hyperparathyroidism Papageorgiou General Hospital
Completed
No outcome recorded
Phase 4
NCT00073710 Sep 2004 → ? chronic kidney disease , secondary hyperparathyroidism Abbott
Completed
No outcome recorded
Phase 4
NCT00091481 Jun 2003 → ? chronic renal failure syndrome Abbott
Completed
No outcome recorded
Phase 4
NCT00062699 Apr 2003 → ? end stage renal failure Abbott
Terminated
No outcome recorded
Phase 4
NCT00053547 Jan 2002 → ? end stage renal failure , secondary hyperparathyroidism of renal origin Abbott
Completed
No outcome recorded
Show 10 more trials Phase not applicable 5 trials · 1 met primary · 2 missed
— NCT01630408 Mar → May 2014 heart failure Massachusetts General Hospital
Withdrawn
No outcome recorded
— NCT02090608 Mar 2012 → Dec 2013 Fabry disease , proteinuria Federico II University
Completed
No outcome recorded
— NCT00800358 Nov 2008 → Oct 2009 chronic kidney disease , secondary hyperparathyroidism Penang Hospital, Malaysia
Completed
Missed primary
— NCT00796679 Oct 2008 → Jun 2011 chronic kidney disease The University of Hong Kong
Completed
Missed primary
— NCT00469625 Jul 2006 → Jan 2008 proteinuria Winthrop University Hospital
Withdrawn
Met primary
Comparator or background therapy 28 trials
Phase 2
NCT03331562 Comparator Dec 2017 → Jun 2020 pancreatic adenocarcinoma Translational Genomics Research Institute
Completed
No outcome recorded
Phase 2
NCT01136564 Comparator Jul 2010 → Dec 2011 chronic kidney disease Erling Bjerregaard Pedersen
Completed
No outcome recorded
Phase 2
NCT01003275 Comparator Oct 2009 → Nov 2011 chronic kidney disease University of Washington
Completed
No outcome recorded
Phase 2
NCT00421733 Comparator Dec 2006 → Jun 2009 diabetic kidney disease Abbott
Completed
No outcome recorded
Phase 2/3
NCT01204528 Comparator Sep 2010 → Jun 2013 chronic kidney disease Danderyd Hospital
Completed
No outcome recorded
Phase 3
NCT01436747 Comparator Jul 2012 → Oct 2014 disease related to solid organ transplantation , proteinuria University Medical Centre Ljubljana
Completed
No outcome recorded
Phase 3
NCT01138475 Comparator Jul 2010 → Aug 2015 secondary hyperparathyroidism Kerstyn C. Zalesin, M.D.
Completed
No outcome recorded
Phase 3
NCT01071070 Comparator Nov 2009 → Nov 2010 chronic kidney disease Abbott
Completed
No outcome recorded
Phase 3
NCT00616902 Comparator Jan → May 2009 end stage renal failure Abbott
Terminated
No outcome recorded
Stop: Enrollment
Phase 3
NCT00646035 Comparator Jan → Nov 2002 end stage renal failure Abbott
Completed
No outcome recorded
Phase 4
NCT03588884 Comparator Jun 2018 → Apr 2020 chronic kidney disease , secondary hyperparathyroidism of renal origin , vitamin D deficiency OPKO Health, Inc.
Completed
No outcome recorded
Phase 4
NCT01442272 Comparator Jan → Oct 2012 chronic renal failure syndrome , vitamin D deficiency Hospital Universitario de Canarias
Unknown
No outcome recorded
Phase 4
NCT01181531 Comparator Oct 2010 → Jul 2012 secondary hyperparathyroidism Amgen
Completed
Missed primary
Phase 4
NCT00977080 Comparator Nov 2009 → May 2011 chronic kidney disease , secondary hyperparathyroidism of renal origin Abbott
Completed
No outcome recorded
Phase 4
NCT01265615 Comparator Oct 2009 → Apr 2010 cardio-renal syndrome , chronic transplant rejection Ural State Medical University
Completed
No outcome recorded
Phase 4
NCT00958451 Comparator Jul 2009 → Jan 2011 chronic kidney disease , secondary hyperparathyroidism of renal origin Salem Veterans Affairs Medical Center
Completed
No outcome recorded
Phase 4
NCT00752102 Comparator Sep 2008 → Oct 2013 calcinosis , chronic kidney disease , vitamin D deficiency Joslin Diabetes Center
Completed
No outcome recorded
Phase 4
NCT00537979 Comparator Sep 2007 → Jul 2010 secondary hyperparathyroidism Abbott
Completed
No outcome recorded
Phase 4
NCT00463021 Background Apr → Dec 2007 secondary hyperparathyroidism of renal origin Genzyme, a Sanofi Company
Completed
No outcome recorded
Phase 4
NCT00257920 Comparator Jun 2006 → Jan 2008 end stage renal failure , secondary hyperparathyroidism of renal origin Abbott
Completed
No outcome recorded
Phase 4
NCT00294866 Comparator Mar 2006 → Jan 2008 kidney failure Fresenius Medical Care North America
Completed
No outcome recorded
— NCT06209268 Comparator May → Oct 2025 overdue infectious disease with sepsis University of Split, School of Medicine
Not yet recruiting
No outcome recorded
— NCT02273570 Background Mar 2015 → Dec 2016 secondary hyperparathyroidism of renal origin Azienda Ospedaliera Sant'Anna
Unknown
No outcome recorded
— NCT01792206 Comparator Sep 2009 → Nov 2012 chronic kidney disease , type 2 diabetes mellitus Scott and White Hospital & Clinic
Unknown
No outcome recorded
— NCT00915876 Comparator Mar 2009 → Mar 2011 chronic kidney disease Amy Barton Pai
Completed
No outcome recorded
— NCT00469599 Comparator Jul 2007 → Sep 2010 chronic kidney disease , secondary hyperparathyroidism of renal origin , vitamin D deficiency Zealand University Hospital
Terminated
No outcome recorded
Stop: Enrollment
— NCT00587158 Comparator Jan 2007 → Nov 2011 end stage renal failure , secondary hyperparathyroidism Mayo Clinic
Completed
No outcome recorded
— NCT00428246 Comparator Nov 2006 → Jul 2007 chronic kidney disease , hypertensive disorder Indiana University
Completed
No outcome recorded
Show 23 more trials